Funding Opportunities

Grants for melanoma and skin cancer clinical research

Melanoma and Skin Cancer Trials conducts investigator-initiated clinical trials and related research to improve how doctors prevent, diagnose and treat melanoma and skin cancer.

We have built an impressive reputation for delivering multicentre trials that improve melanoma and skin cancer outcomes across the world. Since 1999, we have delivered 29 clinical trials involving over 7,500 participants.

Melanoma and Skin Cancer Trials facilitates the development of competitive investigator-initiated proposals through our concept development pathway. For more information on how we can help you develop a research proposal and secure funding, contact us.

MRFF 2022 Frontier Health and Medical Research Grant Opportunity - GO5855

Open Date

13 February 2023

Closing Date

31 March 2024

Grant amount

$25,000,000 AUD

About

This grant scheme provides the opportunity to support medical research that can develop ground-breaking technology for a currently serious and incurable health condition, through a series of linked projects. Applicants may propose to start research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years.

MRFF 2023 Clinical Trials Activity Grant Opportunity - GO6540

Open Date

25 October 2023

Closing Date

29 May 2024

Grant amount

$5,000,000 AUD

Application website

About

Applications to this grant opportunity must propose research that addresses one of the four streams of research.  An application may be submitted to one of the four streams only.

The objective of this grant opportunity is addressed in the following four streams:

Rare Cancers, Rare Diseases and Unmet Need

  • Stream 1– conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need.
  • Stream 2 – conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need.

Effective health interventions

  • Stream 3 – conduct a clinical trial that assesses the comparative effectiveness of two or more health interventions to treat a specific clinical condition, to inform the decisions of policy makers, clinicians, and consumers regarding healthcare and to minimise the use of unnecessary, ineffective, and harmful health interventions.
  • Stream 4 – conduct an implementation science trial to identify scalable strategies for reducing the provision of low value care.

MRFF Multidisciplinary Models of Primary Care - GO6509

Open Date

18 October 2023

Closing Date

10 April 2024

Grant amount

$2,800,000 AUD

About

Develop and implement multidisciplinary, collaborative, regional consortia that design, implement and evaluate (including cost-benefit analyses) system level reform strategies for local health system integration.

Research proposals in this stream must focus on one of the following topics:

  • Topic A: The organisation undertaking the majority of the research is based in any area according to the Modified Monash Model Locator (MM1-7)
  • Topic B: The organisation undertaking the majority of the research, the Chief Investigator A and 50% or more of all Chief Investigators, and all research participants, are primarily resident in a rural, regional or remote area according to the Modified Monash Model Locator (MM2-7).

NHMRC Partnership Projects 2024 - GO6697

Open Date

  • PRC2: 21 March 2024
  • PRC3: 25 July 2024

Closing Date

  • PRC2: 24 July 2024
  • PRC3: 13 November 2024

Grant amount

$1,500,000 AUD

Application website

About

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.

The objectives of the Partnership Project scheme are to:

  • Meet the need for more effective integration of research evidence into health policy and service delivery
  • Create partnerships among policy makers, managers, service providers and researchers
  • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians health and health care
  • Be highly responsive to the priorities of government, the community and health professionals
  • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

NHMRC Clinical Trials and Cohort Studies (Forecast)

Open Date

expected June 2024

Closing Date

expected August 2024

Grant amount

TBA

Application website

About

The objective of the Clinical Trials and Cohort Studies Grant scheme is to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. This grant opportunity is open to research proposals for clinical trials and/or cohort studies of any size – that is, they may be large or small clinical trials or cohort studies.

The intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and wellbeing, health care practice or policy, as a result of:

  • High-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).
  • High-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.
  • High quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.